Homocysteine toxicity in connective Tissue: Theories, old and new

Connective Tissue Research

Volumn 49, Issue 2, 2008, Pages 57-61

  Toohey, John I ^a  

^a Cytoregulation Research   (Canada)

Author keywords

Atherosclerosis; Collagen; Connective Tissue; Dehydroascorbic acid; Homocysteine Thiolactone; Mercaptopropionaldehyde; Osteoporosis

Indexed keywords

ASCORBIC ACID; COLLAGEN; DEHYDROASCORBIC ACID; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; MERCAPTOPROPIONALDEHYDE; NINHYDRIN; PROPIONALDEHYDE; ARYLDIALKYLPHOSPHATASE; THIOL DERIVATIVE;

ANTIGENICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CHEMICAL REACTION KINETICS; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE DISEASE; HYDROXYLATION; HYPERHOMOCYSTEINEMIA; IN VIVO STUDY; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SHORT SURVEY; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; AUTOIMMUNE DISEASES; COLLAGEN; CONNECTIVE TISSUE DISEASES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; SULFHYDRYL COMPOUNDS;

EID: 41649115437     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200801913742     Document Type: Short Survey

References (34)

1. Castro, R., Rivera, I., Blom, H. J., Jakobs, C. and de Almeida, I. T. (2006) Homocysteine metabolism, hyperhomocysteinemia and vascular disease: An overview. J. Inherit. Metab. Dis., 29, pp. 3-20.
2. Gibson, J. B., Carson, N. A. and Neill, D. W. (1964) Pathological findings in homocystinuria. J. Clin. Pathol., 17, pp. 427-437.
3. McCully, K. S. (1996) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol., 56, pp. 111-128.
4. Jackson, S. H. (1973) The reaction of homocysteine with aldehyde: An explanation of the collagen defects in homocystinuria. Clin. Chim. Acta, 45, pp. 215-217.
5. Kang, A. H. and Trelstad, R. L. (1973) A collagen defect in homocystinuria. J. Clin. Invest., 52, pp. 2571-2578.
6. Lubec, B., Fang-Kircher, S., Lubec, T., Blom, H. J. and Boers, G. H. (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim. Biophys. Acta, p. 1315.
7. Liu, G., Nellaiappan, K. and Kagan, H. M. (1997) Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. J. Biol. Chem., 272, pp. 32370-32377.
8. Hermann, M., Hermann, W. and Widman, T. (2006) Re: Elevated serum homocysteine and McCusick's hypothesis of a disturbed collagen cross-linking: What do we really know?. Bone, 39, pp. 1385-1387.
9. Loscalzo, J. (1996) The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest., 98, pp. 5-7.
10. Moat, S. J. and McDowell, I. F. (2005) Homocysteine and endothelial function in human studies. Semin. Vasc. Med., 5, pp. 172-182.
11. Jacobsen, D. W. (2000) Hyperhomocysteinemia and oxidative stress. Time for a reality check. Arterioscler. Throm. Vasc. Biol., 20, pp. 1182-1184.
12. Glushchenko, A. V. and Jacobsen, D. (2007) Molecular targeting of proteins by L-homocysteine: Mechanistic implications for vascular disease. Antioxid. Redox Signal., 9, pp. 1883-1898.
13. Jakubowski, H. (2006) Pathophysiological consequences of homocysteine excess. J. Nutr., 136, pp. 1741-1749.
14. Zhang, C., Cai, Y., Adachi, M. T., Ochiro, S., Aso, T., Kaufman, R. J. and Kitajima, S. (2001) Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J. Biol. Chem., 276, pp. 35867-35874.
15. Austin, R. C., Lentz, S. R. and Werstuch, G. H. (2004) Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombosis. Cell Death Differentiation, 11, pp. S56-S64.
16. Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P., Hine, R. J. and James, S. J. (2000) Increase in plasma homocysteine associated with parallel increase in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem., 275, pp. 29318-29323.
17. Clarke, S. and Banfield, K. (2001) S-Adenosylmethionine-Dependent Methyltransferases. Homocysteine in Health and Disease, pp. 63-75. Cambridge University Press, Cambridge
18. Toohey, J. I. (2007) Mercaptopropionaldehyde from homocysteine: implications for Alzheimer's Disease. J. Alzheimer's Dis., 12, pp. 241-242.
19. Kivirikko, K. I. and Myllyla, R. (1985) Post-translational processing of procollagens. Ann. N. Acad. Sci., 460, pp. 187-201.
20. Myllyla, R., Kuutt-Savolainen, E. and Kivirikko, K. I. (1978) The role of ascorbate in the prolyl hydroxylase reaction. Biochem. Biophys. Res. Commun., 83, pp. 441-448.
21. Padh, H. (1991) Vitamin C: Newer insights into its biochemical functions. Nutr. Rev., 49, pp. 65-79.
22. Wang, S. X., Mure, M., Medzihradszky, K. F., Burlingame, A. L., Brown, D. E., Dooley, D. M., Smith, A. J., Kagan, H. M. and Klinman, J. P. (1996) A crosslinked cofactor in lysyl oxidase: Redox function for amino acid side chains. Science, 273, pp. 1078-1084.
23. Steinhubl, S. R. and Molliterno, D. J. (2005) The role of the platelet in the pathogenesis of atherothrombosis [review]. Am. J. Cardiovasc. Drugs, 5, pp. 399-408.
24. Starkebaum, G. and Harlan, J. M. (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation form homocysteine. J. Clin. Invest., 77, pp. 1370-1376.
25. Hultberg, B., Andersson, A. and Isaksson, A. (1997) The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress. Toxicology, 123, pp. 33-40.
26. Wilson, J. X. (2005) Regulation of Vitamin C transport. Ann. Rev. Nutr., 25, pp. 105-125.
27. Niemela, O. (1999) Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Frontiers in Biosci., 4, pp. 506-513.
28. Smedly, J. (1996) Is formaldehyde an important cause of allergic respiratory disease?. Clin. Exp. Allergy, 26, pp. 247-249.
29. Washko, P. W., Wang, Y. and Levine, M. (1993) Ascorbic acid recycling in human nuetrophils. J. Biol. Chem., 268, pp. 15531-15535.
30. Dierkes, J. and Westphal, S. (2005) Effects of drugs on homocysteine concentrations. Semin. Vasc. Med., 5, pp. 124-139.
31. Herrmann, M., Widmann, T. and Herrmann, W. (2005) Homocysteine-a newly recognized risk factor for osteoporosis. Clin. Chem. Lab. Med., 43, pp. 1111-1117.
32. Lazzerini, P. E., Capecchi, P. L., Selvi, E., Lorenzini, S., Bisogno, S., Galeazzi, M. and Passini, F. Laghi (2007) Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun. Rev., 6, pp. 503-509.
33. Krumdieck, C. L. and Prince, C. W. (2000) Mechanisms of homocysteine toxicity on connective tissues: Implications for the morbidity of aging. J. Nutr., 130, pp. 365S-368S.
34. Bajema, I. M. and Bruijn, J. A. (2000) What stuff is this! A historical perspective on fibrinoid necrosis. J. Pathol., 191, pp. 235-238.